145 related articles for article (PubMed ID: 37858127)
21. Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR.
Miki S; Satomi K; Ohno M; Matsushita Y; Kitahara M; Miyakita Y; Takahashi M; Matsuda M; Ishikawa E; Matsumura A; Yoshida A; Narita Y; Ichimura K
Brain Tumor Pathol; 2020 Oct; 37(4):154-158. PubMed ID: 32749624
[TBL] [Abstract][Full Text] [Related]
22. Combined Detection of Copy Number Variations of MYCN and ALK using Droplet Digital Polymerase Chain Reaction to Identify High-Risk Patients with Neuroblastoma.
Trivedi T; Panchal K; Bhalala N; Trivedi P; Panchal H
World Neurosurg; 2022 Mar; 159():e48-e57. PubMed ID: 34861448
[TBL] [Abstract][Full Text] [Related]
23. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population.
Zhong R; Liu L; Zou L; Zhu Y; Chen W; Zhu B; Shen N; Rui R; Long L; Ke J; Lu X; Zhang T; Zhang Y; Wang Z; Liu L; Sun Y; Cheng L; Miao X
Mol Carcinog; 2013 Nov; 52 Suppl 1():E118-26. PubMed ID: 23908149
[TBL] [Abstract][Full Text] [Related]
24. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer.
Panebianco F; Nikitski AV; Nikiforova MN; Nikiforov YE
Cancer Med; 2019 Oct; 8(13):5831-5839. PubMed ID: 31408918
[TBL] [Abstract][Full Text] [Related]
26. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
Int J Mol Med; 2018 Sep; 42(3):1675-1683. PubMed ID: 29956721
[TBL] [Abstract][Full Text] [Related]
27. Direct activation of TERT transcription by c-MYC.
Wu KJ; Grandori C; Amacker M; Simon-Vermot N; Polack A; Lingner J; Dalla-Favera R
Nat Genet; 1999 Feb; 21(2):220-4. PubMed ID: 9988278
[TBL] [Abstract][Full Text] [Related]
28. Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
Tallet A; Nault JC; Renier A; Hysi I; Galateau-Sallé F; Cazes A; Copin MC; Hofman P; Andujar P; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
Oncogene; 2014 Jul; 33(28):3748-52. PubMed ID: 23975423
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity and telomerase reverse transcriptase expression induced by selenium in rat hepatocytes.
Yu RA; Chen HJ; He LF; Chen B; Chen XM
Biomed Environ Sci; 2009 Aug; 22(4):311-7. PubMed ID: 19950526
[TBL] [Abstract][Full Text] [Related]
30. Effects of cadmium on telomerase activity, expressions of TERT, c-myc and P53, and apoptosis of rat hepatocytes.
Dai W; Chen H; Yu R; He L; Chen B; Chen X
J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):709-13. PubMed ID: 21181359
[TBL] [Abstract][Full Text] [Related]
31. Screening for Copy Number Variations of the 15q13.3 Hotspot in
Özaltun MF; Geyik S; Yılmaz ŞG
Curr Issues Mol Biol; 2021 Sep; 43(2):1090-1113. PubMed ID: 34563047
[TBL] [Abstract][Full Text] [Related]
32. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
Hsu CP; Hsu NY; Lee LW; Ko JL
Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
[TBL] [Abstract][Full Text] [Related]
33. MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis.
Iwakawa R; Kohno T; Kato M; Shiraishi K; Tsuta K; Noguchi M; Ogawa S; Yokota J
Clin Cancer Res; 2011 Mar; 17(6):1481-9. PubMed ID: 21148746
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Hara H; Yamashita K; Shinada J; Yoshimura H; Kameya T
Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
[TBL] [Abstract][Full Text] [Related]
35. Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma.
Lin CS; Lee HT; Lee MH; Pan SC; Ke CY; Chiu AW; Wei YH
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231905
[TBL] [Abstract][Full Text] [Related]
36. Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas.
Buchynska LG; Brieieva OV; Iurchenko NP
Exp Oncol; 2019 Jun; 41(2):138-143. PubMed ID: 31262163
[TBL] [Abstract][Full Text] [Related]
37. PVT1 dependence in cancer with MYC copy-number increase.
Tseng YY; Moriarity BS; Gong W; Akiyama R; Tiwari A; Kawakami H; Ronning P; Reuland B; Guenther K; Beadnell TC; Essig J; Otto GM; O'Sullivan MG; Largaespada DA; Schwertfeger KL; Marahrens Y; Kawakami Y; Bagchi A
Nature; 2014 Aug; 512(7512):82-6. PubMed ID: 25043044
[TBL] [Abstract][Full Text] [Related]
38. [Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma].
Chen TX; Xiong YY; Liu L
Ai Zheng; 2004 Mar; 23(3):273-7. PubMed ID: 15025956
[TBL] [Abstract][Full Text] [Related]
39. Telomerase activity and telomerase reverse transciptase (TERT) expression in ameloblastomas.
Kumamoto H; Kinouchi Y; Ooya K
J Oral Pathol Med; 2001 Apr; 30(4):231-6. PubMed ID: 11302243
[TBL] [Abstract][Full Text] [Related]
40. Copy number determination of the gene for the human pancreatic polypeptide receptor NPY4R using read depth analysis and droplet digital PCR.
Shebanits K; Günther T; Johansson ACV; Maqbool K; Feuk L; Jakobsson M; Larhammar D
BMC Biotechnol; 2019 Jun; 19(1):31. PubMed ID: 31164119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
